Haemonetics to acquire Attune Medical for $160m
Attune Medical’s ensoETM device is designed for oesophageal protection during radiofrequency (RF) cardiac ablation procedures.
ESG in Medical
Sustainability: Q&A with Oxford Product Design’s Steve Green
The shift of environmental, social, and governance issues in medical device companies
ESG – Healthcare: Macroeconomic trends
ESG – Top Trends in Healthcare: Technology trends
ESG: Top three medical device companies leading the way
ESG in clinical trials: what pharma needs to know
Cybersecurity in Medical: Corporate Governance
